|
1
|
Fahad Ullah M: Breast cancer: Current
perspectives on the disease status. Adv Exp Med Biol. 1152:51–64.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coughlin SS: Epidemiology of breast cancer
in women. Adv Exp Med Biol. 1152:9–29. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeSantis CE, Bray F, Ferlay J,
Lortet-Tieulent J, Anderson BO and Jemal A: International variation
in female breast cancer incidence and mortality rates. Cancer
Epidemiol Biomarkers Prev. 24:1495–1506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cancer Statistics, . Cancer Information
Service, National Cancer Center, Japan (National Cancer Registry,
Ministry of Health, Labour and Welfare). https://ganjoho.jp/public/index.html
|
|
5
|
Katanoda K, Ito Y and Sobue T:
International comparison of trends in cancer mortality: Japan has
fallen behind in screening-related cancers. Jpn J Clin Oncol.
51:1680–1686. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grayson M: Breast cancer. Nature.
485:S492012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esnakula AK, Ricks-Santi L, Kwagyan J,
Kanaan YM, DeWitty RL, Wilson LL, Gold B, Frederick WA and Naab TJ:
Strong association of fascin expression with triple negative breast
cancer and basal-like phenotype in African-American women. J Clin
Pathol. 67:153–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamamoto Y, Hayashi Y, Sakaki H and
Murakami I: Fascin-1 is associated with recurrence in solitary
fibrous tumor/hemangiopericytoma. Mol Clin Oncol. 15:1992021.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hayashi Y, Osanai M and Lee GH: Fascin-1
expression correlates with repression of E-cadherin expression in
hepatocellular carcinoma cells and augments their invasiveness in
combination with matrix metalloproteinases. Cancer Sci.
102:1228–1235. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang CQ, Tang CH, Chang HT, Li XN, Zhao
YM, Su CM, Hu GN, Zhang T, Sun XX, Zeng Y, et al: Fascin-1 as a
novel diagnostic marker of triple-negative breast cancer. Cancer
Med. 5:1983–1988. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Arlt MJ, Kuzmanov A, Snedeker JG, Fuchs B,
Silvan U and Sabile AA: Fascin-1 enhances experimental osteosarcoma
tumor formation and metastasis and is related to poor patient
outcome. BMC Cancer. 19:832019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Richmond AM, Blake EA, Torkko K, Smith EE,
Spillman MA and Post MD: Fascin is associated with aggressive
behavior and poor outcome in uterine carcinosarcoma. Int J Gynecol
Cancer. 27:1895–1903. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Allred DC, Harvey JM, Berardo M and Clark
GM: Prognostic and predictive factors in breast cancer by
immunohistochemical analysis. Mod Pathol. 11:155–168.
1998.PubMed/NCBI
|
|
14
|
Yamamoto Y, Hayashi Y, Sakaki H and
Murakami I: Evaluation of clinical and immunohistochemical factors
relating to melanoma metastasis: Potential roles of nestin and
fascin in melanoma. Diagnostics (Basel). 12:2192022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lamb MC, Kaluarachchi CP, Lansakara TI,
Mellentine SQ, Lan Y, Tivanski AV and Tootle TL: Fascin limits
Myosin activity within Drosophila border cells to control substrate
stiffness and promote migration. Elife. 10:e698362021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abbasi A, Noroozinia F, Anvar S, Abbasi M,
Hosseinzadeh S and Mokhtari S: Fascin overexpression is associated
with higher grades of breast cancer. Pol J Pathol. 70:264–268.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xing P, Li JG, Jin F, Zhao TT, Liu Q, Dong
HT and Wei XL: Fascin, an actin-bundling protein, promotes breast
cancer progression in vitro. Cell Biochem Funct. 29:303–310. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arjonen A, Kaukonen R and Ivaska J:
Filopodia and adhesion in cancer cell motility. Cell Adh Migr.
5:421–430. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Peart O: Metastatic breast cancer. Radiol
Technol. 88:519M–539M. 2017.PubMed/NCBI
|
|
20
|
Iqbal J, Ginsburg O, Rochon PA, Sun P and
Narod SA: Differences in breast cancer stage at diagnosis and
cancer-specific survival by race and ethnicity in the United
States. JAMA. 313:165–173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ginsburg O, Yip CH, Brooks A, Cabanes A,
Caleffi M, Dunstan Yataco JA, Gyawali B, McCormack V, McLaughlin de
Anderson M, Mehrotra R, et al: Breast cancer early detection: A
phased approach to implementation. Cancer. 126 (Suppl
10):S2379–S2393. 2020. View Article : Google Scholar
|
|
22
|
Mattila PK and Lappalainen P: Filopodia:
Molecular architecture and cellular functions. Nat Rev Mol Cell
Biol. 9:446–454. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lamb MC and Tootle TL: Fascin in cell
migration: more than an actin bundling protein. Biology (Basel).
9:4032020.PubMed/NCBI
|
|
24
|
Lin S, Li Y, Wang D, Huang C, Marino D,
Bollt O, Wu C, Taylor MD, Li W, DeNicola GM, et al: Fascin promotes
lung cancer growth and metastasis by enhancing glycolysis and
PFKFB3 expression. Cancer Lett. 518:230–242. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Song M, Liu M, Zhang G, Zhang X,
Li MO, Ma X, Zhang JJ and Huang XY: Fascin inhibitor increases
intratumoral dendritic cell activation and anti-cancer immunity.
Cell Rep. 35:1089482021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fox EF, Lamb MC, Mellentine SQ and Tootle
TL: Prostaglandins regulate invasive, collective border cell
migration. Mol Biol Cell. 31:1584–1594. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin S, Taylor MD, Singh PK and Yang S: How
does fascin promote cancer metastasis? FEBS J. 288:1434–1446. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ristic B, Kopel J, Sherazi SAA, Gupta S,
Sachdeva S, Bansal P, Ali A, Perisetti A and Goyal H: Emerging role
of fascin-1 in the pathogenesis, diagnosis, and treatment of the
gastrointestinal cancers. Cancers (Basel). 13:25362021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chung V, Jhaveri KL, Van Hoff DD Von,
Huang XY, Garmey EG, Zhang J and Tsai FYC: Phase 1A clinical trial
of the first-in-class fascin inhibitor NP-G2-044 evaluating safety
and anti-tumor activity in patients with advanced and metastatic
solid tumors. J Clin Oncol. 39 (15 Suppl):S25482021. View Article : Google Scholar
|
|
30
|
JoEllen W: Chapter 40 - Animal Models for
Studying Prevention and Treatment of Breast Cancer. Animal Models
for the Study of Human Disease. Elsevier; Amsterdam: pp. 997–1018.
2013
|
|
31
|
Hoa NT, Ge L, Erickson KL, Kruse CA,
Cornforth AN, Kuznetsov Y, McPherson A, Martini F and Jadus MR:
Fascin-1 knock-down of human glioma cells reduces their
microvilli/filopodia while improving their susceptibility to
lymphocyte-mediated cytotoxicity. Am J Trransl Rransl Res.
7:271–284. 2015.
|
|
32
|
Huang Z, Yu P and Tang J: Characterization
of triple-negative breast cancer MDA-MB-231 cell spheroid model.
Onco Targets Ther. 13:5395–5405. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Trepat X, Chen Z and Jacobson K: Cell
migration. Compr Physiol. 2:2369–2392. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lamb MC, Anliker KK and Tootle TL: Fascin
regulates protrusions and delamination to mediate invasive,
collective cell migration in vivo. Dev Dyn. 249:961–982. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lintz M, Muñoz A and Reinhart-King CA: The
mechanics of single cell and collective migration of tumor cells. J
Biomech Eng. 139:0210051–0210059. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
De Pascalis C and Etienne-Manneville S:
Single and collective cell migration: The mechanics of adhesions.
Mol Biol Cell. 28:1833–1846. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sanada T, Yamaguchi J, Furuta Y, Kakuta S,
Tanida I and Uchiyama Y: In-resin CLEM of Epon-embedded cells using
proximity labeling. Sci Rep. 12:111302022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Peng D, Li N, He W, Drasbek KR, Xu T,
Zhang M and Xu P: Improved fluorescent proteins for dual-colour
post-embedding CLEM. Cells. 11:10772022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Van den Dries K, Fransen J and Cambi A:
Fluorescence CLEM in biology: Historic developments and current
super-resolution applications. FEBP Lett. 596:2486–2496. 2022.
View Article : Google Scholar : PubMed/NCBI
|
